[Webinar] Alcohol Use Disorder Part 1: Epidemiology, Evidence-Based Treatments, and Emerging Therapeutics
Updated: 5 days ago
Alcohol use disorder (AUD) is among the most prevalent substance use disorders in the United States, affecting millions of people each year and contributing to significant health, social, and economic harms. Yet, despite the availability of effective behavioral interventions and medications, many individuals with AUD do not receive treatment.
This webinar provided an introduction to alcohol use and AUD in the United States, including epidemiologic trends, diagnostic criteria, and current treatment approaches. Participants learned about behavioral interventions and FDA-approved medications used to treat AUD, as well as the differing roles of abstinence-oriented and harm-reduction approaches. The session also examined promising areas of emerging research, including novel medications, device-based interventions, and the potential role of GLP-1 receptor agonists in AUD treatment.
Speakers
Katie Witkiewitz, Ph.D., Distinguished Professor, Department of Psychology and Director, Center on Alcohol, Substance Use, and Addictions at the University of New Mexico
Lorenzo Leggio, M.D., Ph.D., Clinical Director and Deputy Scientific Director of the Intramural Research Program at the National Institute on Drug Abuse, NIDA/NIAAA Senior Investigator
Redonna Chandler, Ph.D., Scientific Advisor, Addiction Policy Forum
This webinar is the first in a two-part series. Part two will focus on addressing the unique needs of women with AUD and advancing understanding of recovery trajectories and relapse. To register for Part Two, click here.
